Authors: Lee, RJ Albanese, C Fu, MF D'Amico, M Lin, B Watanabe, G Haines, GK Siegel, PM Hung, MC Yarden, Y Horowitz, JM Muller, WJ Pestell, RG

Citation: Rj. Lee et al., Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway, MOL CELL B, 20(2), 2000, pp. 672-683

Authors: Siegel, PM Hardy, WR Muller, WJ

Citation: Pm. Siegel et al., Mammary gland neoplasia: insights from transgenic mouse models, BIOESSAYS, 22(6), 2000, pp. 554-563

Authors: Andrechek, ER Hardy, WR Siegel, PM Rudnicki, MA Cardiff, RD Muller, WJ

Citation: Er. Andrechek et al., Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis, P NAS US, 97(7), 2000, pp. 3444-3449

Authors: Rauh, MJ Blackmore, V Andrechek, ER Tortorice, CG Daly, R Lai, VKM Pawson, T Cardiff, RD Siegel, PM Muller, WJ

Citation: Mj. Rauh et al., Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein, MOL CELL B, 19(12), 1999, pp. 8169-8179

Authors: Siegel, PM Ryan, ED Cardiff, RD Muller, WJ

Citation: Pm. Siegel et al., Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer, EMBO J, 18(8), 1999, pp. 2149-2164